65. 原発性免疫不全症候群 Primary immunodeficiency Clinical trials / Disease details
臨床試験数 : 500 / 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00640003 (ClinicalTrials.gov) | April 2007 | 14/3/2008 | Baclofen Treatment of Ataxia Telangiectasia | Ataxia Telangiectasia | Drug: Baclofen;Drug: Placebo | Johns Hopkins University | NULL | Completed | 12 Years | N/A | All | 10 | Early Phase 1 | United States |